Clinical experience with tight glucose control by intensive insulin therapy
- 1 September 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 35 (Suppl), S503-S507
- https://doi.org/10.1097/01.ccm.0000278046.24345.c7
Abstract
To describe the current status and the clinical data related to the effects of tight glucose control by intensive insulin therapy in critically ill patients.Journal ArticleReviewinfo:eu-repo/semantics/publisheKeywords
This publication has 31 references indexed in Scilit:
- Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care UnitsDiabetes, 2006
- Poly(ADP-Ribose) Polymerase Inhibitors Ameliorate Nephropathy of Type 2 Diabetic Leprdb/dbMiceDiabetes, 2006
- Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients*Critical Care Medicine, 2006
- Intensive Insulin Therapy in the Medical ICUThe New England Journal of Medicine, 2006
- Hyperglycaemia in critically ill patients: marker or mediator of mortality?Critical Care, 2006
- Oxidative Stress and Diabetes-Associated ComplicationsEndocrine Practice, 2006
- Should minimal blood glucose variability become the gold standard of glycemic control?Journal of Diabetes and its Complications, 2005
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Intensive Insulin Therapy in Critically Ill PatientsThe New England Journal of Medicine, 2001
- Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activationNature Medicine, 2001